Search

Layla D. Berry

Examiner (ID: 310, Phone: (571)272-9572 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1609, 1693, 1673
Total Applications
1764
Issued Applications
1125
Pending Applications
103
Abandoned Applications
569

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18240977 [patent_doc_number] => 20230073288 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-09 [patent_title] => METHODS FOR MONITORING THE PROGRESS OF POLYSACCHARIDE SIZE-REDUCTION [patent_app_type] => utility [patent_app_number] => 17/800271 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6721 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17800271 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/800271
METHODS FOR MONITORING THE PROGRESS OF POLYSACCHARIDE SIZE-REDUCTION Feb 23, 2021 Pending
Array ( [id] => 17080574 [patent_doc_number] => 20210275580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => IRON CARBOHYDRATE COMPLEX FOR TREATMENT OF RESTLESS LEG SYNDROME (RLS) [patent_app_type] => utility [patent_app_number] => 17/182366 [patent_app_country] => US [patent_app_date] => 2021-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8824 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17182366 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/182366
Iron carbohydrate complex for treatment of restless leg syndrome (RLS) Feb 22, 2021 Issued
Array ( [id] => 17967040 [patent_doc_number] => 11484545 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Compounds and methods for treating neurological and cardiovascular conditions [patent_app_type] => utility [patent_app_number] => 17/180469 [patent_app_country] => US [patent_app_date] => 2021-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 28 [patent_no_of_words] => 30062 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17180469 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/180469
Compounds and methods for treating neurological and cardiovascular conditions Feb 18, 2021 Issued
Array ( [id] => 18328272 [patent_doc_number] => 11633489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-25 [patent_title] => Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant [patent_app_type] => utility [patent_app_number] => 17/178430 [patent_app_country] => US [patent_app_date] => 2021-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7105 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178430 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178430
Iron carbohydrate complex for treatment of iron deficiency of a fetus or an infant Feb 17, 2021 Issued
Array ( [id] => 16900740 [patent_doc_number] => 20210179656 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF [patent_app_type] => utility [patent_app_number] => 17/178151 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77145 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 1004 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17178151 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/178151
SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF Feb 16, 2021 Abandoned
Array ( [id] => 18334778 [patent_doc_number] => 20230126726 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-04-27 [patent_title] => CROSSLINKED HYALURONIC ACID AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 17/905871 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7490 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17905871 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/905871
CROSSLINKED HYALURONIC ACID AND USE THEREOF Feb 16, 2021 Pending
Array ( [id] => 16868465 [patent_doc_number] => 20210161932 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST [patent_app_type] => utility [patent_app_number] => 17/176383 [patent_app_country] => US [patent_app_date] => 2021-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7269 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176383 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176383
TREATMENT OF SLEEP APNEA WITH A COMBINATION OF A CARBONIC ANHYDRASE INHIBITOR AND AN ALDOSTERONE ANTAGONIST Feb 15, 2021 Abandoned
Array ( [id] => 18837706 [patent_doc_number] => 11845769 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-19 [patent_title] => Anion exchange stationary phases based on a polyalkylpolyamine polymer layer [patent_app_type] => utility [patent_app_number] => 17/176044 [patent_app_country] => US [patent_app_date] => 2021-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 11725 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 259 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17176044 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/176044
Anion exchange stationary phases based on a polyalkylpolyamine polymer layer Feb 14, 2021 Issued
Array ( [id] => 16885470 [patent_doc_number] => 20210171665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-10 [patent_title] => POROUS POLYMERIC CELLULOSE PREPARED VIA CELLULOSE CROSSLINKING [patent_app_type] => utility [patent_app_number] => 17/248915 [patent_app_country] => US [patent_app_date] => 2021-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7242 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17248915 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/248915
Porous polymeric cellulose prepared via cellulose crosslinking Feb 11, 2021 Issued
Array ( [id] => 17874321 [patent_doc_number] => 11446313 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-20 [patent_title] => Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof [patent_app_type] => utility [patent_app_number] => 17/173340 [patent_app_country] => US [patent_app_date] => 2021-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 27851 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17173340 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/173340
Methods of treating Alport syndrome using bardoxolone methyl or analogs thereof Feb 10, 2021 Issued
Array ( [id] => 16868464 [patent_doc_number] => 20210161931 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-03 [patent_title] => BILE ACID SYNTHESIS PROMOTER, COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS AND FOOD COMPOSITION FOR PROMOTING BILE ACID SYNTHESIS [patent_app_type] => utility [patent_app_number] => 17/171545 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5744 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17171545 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/171545
Bile acid synthesis promoter, composition for promoting bile acid synthesis and food composition for promoting bile acid synthesis Feb 8, 2021 Issued
Array ( [id] => 16839567 [patent_doc_number] => 20210147579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => WATER-SOLUBLE CELLULOSE ETHER AND METHOD FOR PRODUCING THE SAME [patent_app_type] => utility [patent_app_number] => 17/158714 [patent_app_country] => US [patent_app_date] => 2021-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13397 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17158714 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/158714
WATER-SOLUBLE CELLULOSE ETHER AND METHOD FOR PRODUCING THE SAME Jan 25, 2021 Abandoned
Array ( [id] => 17399672 [patent_doc_number] => 20220041762 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-10 [patent_title] => LOW-MOLECULAR-WEIGHT TREMELLA AURANTIALBA GLUCURONOXYLOMANNAN AS WELL AS PREPARATION METHOD AND APPLICATION THEREOF [patent_app_type] => utility [patent_app_number] => 17/429908 [patent_app_country] => US [patent_app_date] => 2021-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5398 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17429908 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/429908
Low-molecular-weight Jan 5, 2021 Issued
Array ( [id] => 16807834 [patent_doc_number] => 20210130387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-06 [patent_title] => PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS [patent_app_type] => utility [patent_app_number] => 17/142936 [patent_app_country] => US [patent_app_date] => 2021-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16431 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17142936 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/142936
PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS Jan 5, 2021 Abandoned
Array ( [id] => 18043647 [patent_doc_number] => 11517580 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-12-06 [patent_title] => Fucosyltransferase specific inhibition using fucose mimetics [patent_app_type] => utility [patent_app_number] => 17/136839 [patent_app_country] => US [patent_app_date] => 2020-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 15397 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17136839 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/136839
Fucosyltransferase specific inhibition using fucose mimetics Dec 28, 2020 Issued
Array ( [id] => 16792959 [patent_doc_number] => 20210122776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 17/135256 [patent_app_country] => US [patent_app_date] => 2020-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26743 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 242 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17135256 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/135256
COMPOUNDS AND METHODS FOR TREATING BACTERIAL INFECTIONS Dec 27, 2020 Abandoned
Array ( [id] => 18212803 [patent_doc_number] => 20230059067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-02-23 [patent_title] => HIGH-SOLUBILITY REBAUDIOSIDE D COMPLEX [patent_app_type] => utility [patent_app_number] => 17/788906 [patent_app_country] => US [patent_app_date] => 2020-12-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16428 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788906 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/788906
High-solubility rebaudioside D complex Dec 24, 2020 Issued
Array ( [id] => 18428699 [patent_doc_number] => 11673909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-13 [patent_title] => Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof [patent_app_type] => utility [patent_app_number] => 17/786133 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9096 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17786133 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/786133
Furaneone glycoside compound, pharmaceutical composition thereof, preparation method therefor, and application thereof Dec 17, 2020 Issued
Array ( [id] => 18224544 [patent_doc_number] => 20230063538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-02 [patent_title] => LARGE SCALE PROCESS [patent_app_type] => utility [patent_app_number] => 17/785295 [patent_app_country] => US [patent_app_date] => 2020-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13994 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17785295 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/785295
LARGE SCALE PROCESS Dec 15, 2020 Pending
Array ( [id] => 17578754 [patent_doc_number] => 20220135609 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => Mannose Derivatives for Treating Bacterial Infections [patent_app_type] => utility [patent_app_number] => 17/120441 [patent_app_country] => US [patent_app_date] => 2020-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61096 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17120441 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/120441
Mannose derivatives for treating bacterial infections Dec 13, 2020 Issued
Menu